Structure Database (LMSD)

LMSD: Structure-based search results

LM_IDCommon NameSystematic NameFormulaMassMain ClassSub Class
LMFA04020016δ18-14-NeuroF(4Z,7Z,10Z)-13-hydroxy-13-(4-hydroxy-5-
((E)-3-hydroxypent-1-en-1-yl)
tetrahydrofuran-2-yl)trideca-4,7,10-
trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020049(13R,16R,20R)-d18-14-NeuroF[14R,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020050(13R,16R,20R)-d18-14-NeuroF[14R,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020051(13R,16R,20R)-d18-14-NeuroF[14S,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020052(13R,16R,20R)-d18-14-NeuroF[14S,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020053(13R,16R,20S)-d18-14-NeuroF[14R,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020054(13R,16R,20S)-d18-14-NeuroF[14R,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020055(13R,16R,20S)-d18-14-NeuroF[14S,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020056(13R,16R,20S)-d18-14-NeuroF[14S,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020057(13R,16S,20R)-d18-14-NeuroF[14R,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020058(13R,16S,20R)-d18-14-NeuroF[14R,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020059(13R,16S,20R)-d18-14-NeuroF[14S,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020060(13R,16S,20R)-d18-14-NeuroF[14S,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020061(13R,16S,20S)-d18-14-NeuroF[14R,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020062(13R,16S,20S)-d18-14-NeuroF[14R,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020063(13R,16S,20S)-d18-14-NeuroF[14S,17R](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020064(13R,16S,20S)-d18-14-NeuroF[14S,17S](R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020065(13S,16R,20R)-d18-14-NeuroF[14R,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020066(13S,16R,20R)-d18-14-NeuroF[14R,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020067(13S,16R,20R)-d18-14-NeuroF[14S,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020068(13S,16R,20R)-d18-14-NeuroF[14S,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020069(13S,16R,20S)-d18-14-NeuroF[14R,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020070(13S,16R,20S)-d18-14-NeuroF[14R,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020071(13S,16R,20S)-d18-14-NeuroF[14S,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020072(13S,16R,20S)-d18-14-NeuroF[14S,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4R,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020073(13S,16S,20R)-d18-14-NeuroF[14R,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020074(13S,16S,20R)-d18-14-NeuroF[14R,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020075(13S,16S,20R)-d18-14-NeuroF[14S,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5R)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020076(13S,16S,20R)-d18-14-NeuroF[14S,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)
-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020077(13S,16S,20S)-d18-14-NeuroF[14R,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020078(13S,16S,20S)-d18-14-NeuroF[14R,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020079(13S,16S,20S)-d18-14-NeuroF[14S,17R](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5R)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020080(13S,16S,20S)-d18-14-NeuroF[14S,17S](S,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)
-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
10-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]